FTC takes aim at pharma patent tactics used to block generics
BioPharma
Source: biopharmadive.com
Stay updated with breaking news from Rick Weissenstein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Washington got a glimpse this week of Democrats’ desired drug-pricing legislative agenda if they win a supermajority.
Merck's lawsuit is the likely start of a flurry of litigation to sink Democrats' signature effort to tackle drug costs.
Cannabis, health care, energy, technology and other equities could swing immediately after the Congressional elections, depending on the outcome.